Solarea Bio
PrivateLast Round
Grant
Aug 23, 2023
Total Funding Raised
$14.4M
Company Overview
Solarea Bio operates in Healthcare & Life Sciences and is based in Waltham, Massachusetts. Its latest recorded funding round was a Grant round in August 2023.
Solarea Bio is a biotechnology company that develops microbiome-based medical foods and therapeutics designed to address age-related inflammatory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Clinical Trials, Medical AI
Business Model
B2C
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Solarea Bio Comparables
Compare Solarea Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pendulum Therapeutics | 65% | |
| Symrise AG | 64% | |
| BioGaia AB (publ) | 62% |
For institutional investors. Book with your work email.
Solarea Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 23, 2023 | ||||
| Series B | May 8, 2023 | ||||
| Series A | Oct 19, 2020 | ||||
| Accelerator | Jul 26, 2017 |
For institutional investors. Book with your work email.
Solarea Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Viking Global Investors | Series A, Series B |
| National Institute on Aging | Grant |
| BOLD Capital Partners | Series B, Series A |
| S2G Investments | Series A, Series B |
| Illumina Accelerator | Accelerator |
Solarea Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Solarea Bio's valuation, stock price, and market status.
Is Solarea Bio a public or private company?
Solarea Bio is a private company.
What is the current stock price of Solarea Bio?
Solarea Bio is a private company, so its shares have no public market price. Caplight tracks Solarea Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Solarea Bio worth (valuation)?
Valuation information for Solarea Bio is not publicly available.
Can I buy Solarea Bio stock?
Solarea Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Solarea Bio's last funding round?
Solarea Bio's most recent funding round was Grant on August 23, 2023.
Who are the main investors in Solarea Bio?
Key investors in Solarea Bio include BOLD Capital Partners, S2G Investments.
Will Solarea Bio IPO soon?
No public IPO plans have been announced for Solarea Bio.
How can I track Solarea Bio secondary market activity?
Caplight tracks bids, offers, and trades in Solarea Bio's shares on secondary markets.